Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ACUR - ACURA PHARMACEUTICALS INC
Market Cap 26.40K P/E - EPS this Y - Ern Qtrly Grth -
Income -879k Forward P/E 0.00 EPS next Y - 50D Avg Chg -98.00%
Sales 1.56M PEG - EPS past 5Y 58.88% 200D Avg Chg -99.00%
Dividend N/A Price/Book 0.13 EPS next 5Y - 52W High Chg -100.00%
Recommedations - Quick Ratio 0.43 Shares Outstanding 66M 52W Low Chg 100.00%
Insider Own 84.28% ROA -58.46% Shares Float 9.94M Beta 49.70
Inst Own 2.95% ROE - Shares Shorted/Prior 89.85K/76K Price 0.00040
Gross Margin 2.50% Profit Margin -56.24% Avg. Volume 1,489 Target Price -
Oper. Margin -658.33% Earnings Date - Volume 785 Change 0.00%
Healthcare | Drug Manufacturers - Specialty & Generic | United States
About ACURA PHARMACEUTICALS INC

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was formerly known as Halsey Drug Co., Inc. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals, Inc. operates as a subsidiary of Abuse Deterrent Pharma, LLC.

ACUR Chatroom

User Image risenhoover Posted - 10 months ago

$ACUR / Acura Pharmaceuticals files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported): January 8, 2024 ACURA PHARMACEUT https://fintel.io/doc/sec-acura-pharmaceuticals-inc-786947-8k-2024-january-10-19732-8019?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image cctranscripts Posted - 10 months ago

Acura: Amended Loan Schedule To Secured Promissory Note Dated November 10, 2022 https://www.conferencecalltranscripts.org/summary/?id=12858290 $ACUR

User Image Last10K Posted - 10 months ago

$ACUR just filed with the SEC a New Agreement, a Change in Assets, a New Financial Obligation and a Financial Exhibit https://last10k.com/sec-filings/ACUR/0001104659-24-003020.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ACUR

User Image cctranscripts Posted - 10 months ago

Acura Pharmaceuticals director just picked up 50,000 shares https://www.conferencecalltranscripts.org/summary/?id=12834293 $ACUR

User Image cctranscripts Posted - 10 months ago

Acura Pharmaceuticals director just picked up 37,500 shares https://www.conferencecalltranscripts.org/summary/?id=12834287 $ACUR

User Image cctranscripts Posted - 10 months ago

Acura Pharmaceuticals director just picked up 50,000 shares https://www.conferencecalltranscripts.org/summary/?id=12834286 $ACUR

User Image cctranscripts Posted - 10 months ago

Acura: Amended, Consolidated And Restated SECURED PROMISSORY NOTE https://www.conferencecalltranscripts.org/summary/?id=12814005 $ACUR

User Image Last10K Posted - 10 months ago

$ACUR just filed with the SEC a New Agreement, a Change in Assets, a New Financial Obligation and a Financial Exhibit https://last10k.com/sec-filings/ACUR/0001104659-23-128084.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ACUR

User Image risenhoover Posted - 10 months ago

$ACUR / Acura Pharmaceuticals files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported): December 7, 2023 ACURA PHARMACEU https://fintel.io/doc/sec-acura-pharmaceuticals-inc-786947-8k-2023-december-21-19712-9849?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Last10K Posted - 11 months ago

$ACUR just filed with the SEC a New Agreement, a Change in Assets, a New Financial Obligation and a Financial Exhibit https://last10k.com/sec-filings/ACUR/0001104659-23-123925.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ACUR

User Image cctranscripts Posted - 11 months ago

Acura: Amended Loan Schedule To Secured Promissory Note Dated November 10, 2022 https://www.conferencecalltranscripts.org/summary/?id=12769987 $ACUR

User Image cctranscripts Posted - 1 year ago

Notification of inability to timely file Form 10-Q or 10-QSB https://www.conferencecalltranscripts.org/summary/?id=12672575 $ACUR

User Image cctranscripts Posted - 1 year ago

Acura: Amended Loan Schedule To Secured Promissory Note Dated November 10, 2022 https://www.conferencecalltranscripts.org/summary/?id=12610616 $ACUR

User Image cctranscripts Posted - 09/25/23

Departure of Directors or Certain https://www.conferencecalltranscripts.org/summary/?id=12564524 $ACUR

User Image risenhoover Posted - 1 year ago

$ACUR / Acura Pharmaceuticals files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported): August 30, 2023 ACURA PHARMACEUT https://fintel.io/sf/us/acur?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image cctranscripts Posted - 1 year ago

Acura: Amended Loan Schedule To Secured Promissory Note Dated November 10, 2022 https://www.conferencecalltranscripts.org/summary/?id=12507690 $ACUR

User Image cctranscripts Posted - 08/31/23

Two known hydrocodone derivatives continues tobe detected in the CRT https://www.conferencecalltranscripts.org/summary/?id=12505544 $ACUR

User Image cctranscripts Posted - 08/30/23

Study 311 was a https://www.conferencecalltranscripts.org/summary/?id=12501044 $ACUR

User Image EarningsInsider Posted - 1 year ago

Acura Pharmaceuticals, Inc. Files SEC Form 8-K $ACUR https://www.marketbeat.com/stocks/OTCMKTS/ACUR/sec-filings/

User Image Last10K Posted - 1 year ago

$ACUR just filed with the SEC a Ending Agreement and a Change in Assets https://last10k.com/sec-filings/ACUR/0001104659-23-092338.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ACUR

User Image cctranscripts Posted - 1 year ago

On August https://www.conferencecalltranscripts.org/summary/?id=12463274 $ACUR

User Image risenhoover Posted - 1 year ago

$ACUR / Acura Pharmaceuticals files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported): August 14, 2023 ACURA PHARMACEUT https://fintel.io/sf/us/acur?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image cctranscripts Posted - 1 year ago

Notification of inability to timely file Form 10-Q or 10-QSB https://www.conferencecalltranscripts.org/summary/?id=12442505 $ACUR

User Image risenhoover Posted - 1 year ago

$ACUR / Acura Pharmaceuticals files form NT 10-Q https://fintel.io/sf/us/acur?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Last10K Posted - 07/28/23

$ACUR just filed with the SEC a New Agreement, a Change in Assets, a New Financial Obligation and a Financial Exhibit https://last10k.com/sec-filings/ACUR/0001104659-23-085361.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ACUR

User Image cctranscripts Posted - 07/28/23

Acura: Amended Loan Schedule To Secured Promissory Note Dated November 10, 2022 https://www.conferencecalltranscripts.org/summary/?id=12398437 $ACUR

User Image risenhoover Posted - 07/28/23

$ACUR / Acura Pharmaceuticals files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported): July 28, 2023 ACURA PHARMACEUTIC https://fintel.io/sf/us/acur?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image EarningsInsider Posted - 07/28/23

Acura Pharmaceuticals, Inc. Files SEC Form 8-K $ACUR https://www.marketbeat.com/stocks/OTCMKTS/ACUR/sec-filings/

User Image Last10K Posted - 07/28/23

$ACUR just filed with the SEC a Accountant Change https://last10k.com/sec-filings/ACUR/0001104659-23-085172.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ACUR

User Image risenhoover Posted - 07/28/23

$ACUR / Acura Pharmaceuticals files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported): July 28, 2023 ACURA PHARMACEUTIC https://fintel.io/sf/us/acur?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

Analyst Ratings
Roth Capital Buy Mar 11, 16
MLV & Co. Buy Feb 27, 15
MLV & Co. Hold May 28, 14
McNicoll Lewis Vlak Buy Aug 14, 13